Clinical trial
A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and…
NCT00299351 · Royal Marsden NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00299351 |
|---|---|
| Title | A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide. |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peripheral T Cell Lymphoma (PTCL) |
| Intervention type | Drug |
| Interventions | Depsipeptide |
| Enrollment | 8 |
| First posted | Mar 6, 2006 |
| Last update posted | Mar 6, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: